Introduction
Measurement of protein biomarkers in body fluids such as blood and urine is important to understand physiological and pathological state [1, 2] . The most widely used for protein analysis in clinic and experimental laboratories is the enzyme-linked immunosorbent assay (ELISA), due to their specificity and sensitivity. This fundamental principle is antigen-antibody specific binding where a capture antibody (1st antibody) immobilized on a solid substrate will react with its corresponding antigen, then which will react with an enzyme-labeled antibody (2nd antibody). ELISA is conventionally performed on disposable 96-well microtitration plates. However, this method consumes relatively large sample volumes (50-100 l) and requires considerable incubation time (2 hr or more) [3] .
Recently, the analysis of biomarkers at near patient which is called point-of-care testing (POCT) is a continuously expanding trend in the practice of laboratory diagnosis [4] . To overcome disadvantages of conventional ELISA method, miniaturization in microfluidic systems is widely used [5] . Microfluidic immunoassays could reduce analysis time, because increased surface area to volume ratios speeds up antigen-antibody reactions [6] . We developed sandwich ELISA on cyclic olefin copolymer (COC) microchip [7] . For this, we employed the piezoelectric inkjet printing for deposition and fixation of 1st antibody on microchannnel surface (300 m width and 100 m depth). We previously reported that carboxyterminal propeptide of type I procollagen (PICP), which was a biomarker for bone formation, could measure only 30-min incubation. Although the normal range of serum PICP is ng/ml level, the normal range of other biomarkers are various from pg/ml to g/ml level. Therefore, more sensitive assay system is required.
In the present study, we selected interleukin-6 (IL-6) as a model analyte, because the normal plasma IL-6 level is less than 4 pg/ml. IL-6 is one of the inflammatory cytokine, and has been implicated in the pathogenesis of a number of inflammatory conditions, such as rheumatoid arthritis, cardiovascular disease [8] . To archive high sensitivity, we examined the concentration and the spotting pattern of 1st antibody on the microchannel. Furthermore, we examined the feasibility of determining plasma concentration of IL-6 in microchannel was comparable to that obtained by the conventional sandwich ELISA using the 96-well microtitration plates. Our new microchip method could detect 2 pg/ml of IL-6 and quantitatively measure the range of 0-32 pg/ml for 35-min incubation. We demonstrated possible application of microchip for monitoring plasma IL-6 level and its potential for POCT.
Materials and methods

Principle
Schematic illustrations of sandwich ELISA on microchip for the determination of plasma IL-6 are shown in Figure 1 . 
Reagents and analytical procedure
Human IL-6 ELISA MAX Deluxe was purchased from BioLegend (Sandiego, USA) and employed for the determination of the plasma concentration of IL-6 with a microtitration plate as the conventional method according to the supplied instructions.
Analysis of IL-6 on the microchip
For the sandwich ELISA on the microchip, we used the same monoclonal anti-IL-6 antibodies that were used in the Human IL-6 ELISA MAX Deluxe for 96-well of microtitration plates. For the deposition and fixation of 1st antibody in spotting buffer on the surface of the microchannel, a piezoelectric inkjet printing system (Cluster Technology Co., Ltd. Osaka, Japan) was employed. The volume of the ejected from the inkjet nozzle was 65 pl, and 60 drops were spotted onto the microchannel surface. After sealing of the microchip surface with a cover film (TOYO INK MFG. CO., LTD, Tokyo, Japan), blocking solution (Block Ace : DS Pharma Biomedical, Osaka, Japan) was infused into each microchannel, and the microchip was left undisturbed for 4 hr at room temperature. After washing of microchannel with 0.05% TritonX in PBS, 2 l of antigen, biotin-labeled 2nd antibody, and avidin-labeled peroxidase were infused into the microchannel and incubated for 20 min, 10 min, and 5 min, respectively. After that, 2 l of substrate solution (SuperSignal West Femto Maximum Sensitivity Substrate : Thermo Scientific, Rockford, IL, USA) for peroxidase reaction was infused into the microchannel. The chemiluminescence intensity of each spot was detected using ImageQuant TM LAS4000 (GE Healthcare Bio-Sciences, Uppsala, Sweden) and its integration value was analyzed using ImageQuant TL (GE Healthcare Bio-Sciences).
Blood sample preparation
Peripheral venous blood samples were collected from healthy subjects by standard venipuncture. All blood samples were collected into EDTA-coated evacuated blood container tubes (TERUMO, Tokyo, Japan), and then the plasma were obtained by centrifugation at 800 x g for 10 min. The plasma was then stored at -80℃ until used. When using the experiment of comparative analysis of the microchip method and the conventional microtitration plate method, purified IL-6 antigen (BioLegend) was added to the plasma, because the conventional microtitratin plate method could not accurately determine the healthy subjects under the detection limit (4 pg/ml).
Ethics
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Results and discussion
To archive high sensitivity in short incubation time, we examined the concentration of 1st antibody on the surface of the microchannel. Using high concentration of 1st antibody, we could detect 2 pg/ml of purified IL-6 solution in 35 min (Figure 2) . Furthermore, the fixation area of 1st antibody was changed from 1 spot to 3 spots, luminescence intensity was increased 3 times (Figure 2) .
The relationship between the concentrations of purified IL-6 in the range of 0-32 pg/ml and the luminescence intensity derived from avidin-labeled peroxidase was examined (Figure 3 ). Three spots of 1st anti-IL-6 antibody were deposited into each microchannel for triplicate determinations, and purified IL-6 solution (0-32 pg/ml), biotin-labeled 2nd anti-IL-6 antibody, avidin-labeled peroxidase were infused into each microchannel. The luminescence increased in a IL-6 concentration dependent manner. The mean (±SD) of luminescence intensity for the 3 different spots at each purified IL-6 concentration was obtained and plotted against the dose, giving a good relationship between the range of 0-32 pg/ml (R 2 =0.9987, Figure 3 ). The detection limit was 2 pg/ml. This range is sufficient for clinical estimation of IL-6 concentration in the blood. These data indicated that this sandwich ELISA preformed on a microchip with aid of piezoelectric printing technology is suitable for the determination of plasma IL-6 concentrations. Plasma IL-6 concentration in 4 subjects were calculated by reference to the standard curve generated from data obtained from the sandwich ELISA on microchip. Each estimated plasma IL-6 concentration was compared with the results obtained by using the 96-well microtitration plate commonly used in clinical laboratories. As shown in Figure 4 , linear regression analysis of these IL-6 concentration obtained by both methods revealed a significant relationship (R 2 =0.9964, Figure 4 ). This result indicated that accurate determination of plasma IL-6 could be performed by use of our new methods. 
Conclusion
Sandwich ELISA preformed on a microchip could detect 2 pg/ml of IL-6 for 35-min incubation. This assay reduced the time for the antigen-antibody reaction to 1/6, and the consumption of sample and reagent to 1/50 compared with conventional method. Furthermore, this assay enables us to determine plasma IL-6 with accuracy, and will be applicable to clinic diagnosis.
